Relx Plc $RELX Shares Bought by Marks Group Wealth Management Inc

Marks Group Wealth Management Inc grew its stake in Relx Plc (NYSE:RELX) by 1.0% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 23,789 shares of the technology company’s stock after purchasing an additional 243 shares during the period. Marks Group Wealth Management Inc’s holdings in Relx were worth $1,293,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Bleakley Financial Group LLC grew its position in shares of Relx by 1.5% during the 1st quarter. Bleakley Financial Group LLC now owns 14,147 shares of the technology company’s stock valued at $713,000 after acquiring an additional 207 shares during the period. Cynosure Group LLC boosted its position in Relx by 3.5% during the first quarter. Cynosure Group LLC now owns 6,951 shares of the technology company’s stock worth $350,000 after purchasing an additional 236 shares in the last quarter. Bridgewater Advisors Inc. grew its holdings in Relx by 2.1% in the first quarter. Bridgewater Advisors Inc. now owns 11,463 shares of the technology company’s stock valued at $617,000 after purchasing an additional 238 shares during the period. UMB Bank n.a. increased its position in shares of Relx by 19.1% in the second quarter. UMB Bank n.a. now owns 1,634 shares of the technology company’s stock valued at $89,000 after buying an additional 262 shares in the last quarter. Finally, Fortis Capital Advisors LLC raised its stake in shares of Relx by 3.1% during the 2nd quarter. Fortis Capital Advisors LLC now owns 9,389 shares of the technology company’s stock worth $510,000 after buying an additional 279 shares during the period. 15.02% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research firms recently issued reports on RELX. Wall Street Zen cut shares of Relx from a “buy” rating to a “hold” rating in a research note on Friday, September 5th. Morgan Stanley reiterated an “overweight” rating on shares of Relx in a research report on Thursday, September 11th. Kepler Capital Markets upgraded shares of Relx from a “hold” rating to a “strong-buy” rating in a research report on Thursday, September 18th. Finally, Weiss Ratings reissued a “buy (b)” rating on shares of Relx in a research note on Saturday, September 27th. One investment analyst has rated the stock with a Strong Buy rating and five have issued a Buy rating to the stock. According to MarketBeat, Relx presently has a consensus rating of “Buy”.

Relx Trading Down 0.0%

RELX opened at $46.40 on Tuesday. The company has a debt-to-equity ratio of 2.55, a current ratio of 0.47 and a quick ratio of 0.42. The stock has a market capitalization of $85.04 billion, a price-to-earnings ratio of 24.95, a PEG ratio of 3.03 and a beta of 0.87. The business has a fifty day moving average price of $47.74 and a 200 day moving average price of $50.95. Relx Plc has a 12 month low of $44.19 and a 12 month high of $56.33.

Relx Cuts Dividend

The company also recently disclosed a semi-annual dividend, which was paid on Tuesday, September 16th. Stockholders of record on Friday, August 8th were issued a $0.2634 dividend. This represents a dividend yield of 170.0%. The ex-dividend date was Friday, August 8th. Relx’s dividend payout ratio (DPR) is presently 27.96%.

About Relx

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.